H.R. 2319

119th Congress

Reported

Women and Lung Cancer Research and Preventive Services Act of 2025

Sponsored byDemocrat:Rep. Boyle, Brendan F. [D-PA-2]PA· Introduced 25 March 2025
Open on Congress.gov

2

Cosponsors

15

Actions

0

Amendments

1

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.

22 April 2026·3 months ago

Summary

Reported to House · Updated 2 April 2026

Women and Lung Cancer Research and Preventive Services Act of 2025

This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations.

The review must

  • report on the status of existing research and current knowledge gaps;
  • identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and
  • provide recommendations for a national lung cancer screening strategy and public education campaign.

Timeline

15 actions

  1. Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.

    22 April 2026 · Calendars

  2. Mrs. Harshbarger moved to suspend the rules and pass the bill.

    21 April 2026 · Floor

  3. Considered under suspension of the rules. (consideration: CR H3020-3021)

    21 April 2026 · Floor

  4. DEBATE - The House proceeded with forty minutes of debate on H.R. 2319.

    21 April 2026 · Floor

  5. On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)

    21 April 2026 · Floor

  6. Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)

    21 April 2026 · Floor

  7. Motion to reconsider laid on the table Agreed to without objection.

    21 April 2026 · Floor

  8. Placed on the Union Calendar, Calendar No. 332.

    18 November 2025 · Calendars

  9. Reported by the Committee on Energy and Commerce. H. Rept. 119-382.

    18 November 2025 · Committee

  10. Reported by the Committee on Energy and Commerce. H. Rept. 119-382.

    18 November 2025 · Committee

  11. Committee Consideration and Mark-up Session Held

    29 April 2025 · Committee

  12. Ordered to be Reported by Voice Vote.

    29 April 2025 · Committee

  13. Referred to the House Committee on Energy and Commerce.

    25 March 2025 · IntroReferral

  14. Introduced in House

    25 March 2025 · IntroReferral

  15. Introduced in House

    25 March 2025 · IntroReferral

Sponsorship

2 cosponsors

Sponsor

Democrat:Rep. Boyle, Brendan F. [D-PA-2]PA

Cosponsors

  • Republican2100%

Classification

Policy area

Health

Legislative subjects

CancerCardiovascular and respiratory healthGovernment studies and investigationsHealth care coverage and accessHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsWomen's health

Committees

1

  • Energy and Commerce Committee

    House · Standing

    • Referred To25 Mar 2025
    • Markup By29 Apr 2025
    • Reported By19 Nov 2025

Reports

Cosponsor momentum

Cumulative over time

Cosponsors grew from 0 on 25 March 2025 to 2 on 15 September 2025.

Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.